259 related articles for article (PubMed ID: 31274145)
21. Atrial fibrillation and acute myocardial infarction: antithrombotic therapy and outcomes.
Lopes RD; Li L; Granger CB; Wang TY; Foody JM; Funk M; Peterson ED; Alexander KP
Am J Med; 2012 Sep; 125(9):897-905. PubMed ID: 22795814
[TBL] [Abstract][Full Text] [Related]
22. Antithrombotic therapy in patients with non-valvular atrial fibrillation undergoing percutaneous coronary intervention: should we change our practice after the PIONEER AF-PCI and RE-DUAL PCI trials?
Duerschmied D; Brachmann J; Darius H; Frey N; Katus HA; Rottbauer W; Schäfer A; Thiele H; Bode C; Zeymer U
Clin Res Cardiol; 2018 Jul; 107(7):533-538. PubMed ID: 29679144
[TBL] [Abstract][Full Text] [Related]
23. Duration of Triple Antithrombotic Therapy and Outcomes Among Patients Undergoing Percutaneous Coronary Intervention.
Koskinas KC; Räber L; Zanchin T; Pilgrim T; Stortecky S; Hunziker L; Blöchlinger S; Billinger M; Gartwyl F; Moro C; Moschovitis A; Jüni P; Heg D; Windecker S
JACC Cardiovasc Interv; 2016 Jul; 9(14):1473-83. PubMed ID: 27478115
[TBL] [Abstract][Full Text] [Related]
24. Ischemic and bleeding events in patients with myocardial infarction undergoing percutaneous coronary intervention who require oral anticoagulation: Insights from the Canadian observational AntiPlatelet sTudy.
Sra S; Tan MK; Mehta SR; Fisher HN; Déry JP; Welsh RC; Eisenberg MJ; Overgaard CB; Rose BF; Siega AJ; Cheema AN; Wong BY; Henderson MA; Lutchmedial S; Lavi S; Goodman SG; Yan AT;
Am Heart J; 2016 Oct; 180():82-9. PubMed ID: 27659886
[TBL] [Abstract][Full Text] [Related]
25. Prevalence, Management, and Long-Term (6-Year) Outcomes of Atrial Fibrillation Among Patients Receiving Drug-Eluting Coronary Stents.
Choi HI; Ahn JM; Kang SH; Lee PH; Kang SJ; Lee SW; Kim YH; Lee CW; Park SW; Park DW; Park SJ
JACC Cardiovasc Interv; 2017 Jun; 10(11):1075-1085. PubMed ID: 28527773
[TBL] [Abstract][Full Text] [Related]
26. Triple vs Dual Antithrombotic Therapy in Patients with Atrial Fibrillation and Coronary Artery Disease.
Lopes RD; Rao M; Simon DN; Thomas L; Ansell J; Fonarow GC; Gersh BJ; Go AS; Hylek EM; Kowey P; Piccini JP; Singer DE; Chang P; Peterson ED; Mahaffey KW
Am J Med; 2016 Jun; 129(6):592-599.e1. PubMed ID: 26797080
[TBL] [Abstract][Full Text] [Related]
27. Long-term antiplatelet therapy following myocardial infarction: implications of PEGASUS-TIMI 54.
Parker WA; Storey RF
Heart; 2016 May; 102(10):783-9. PubMed ID: 26857211
[TBL] [Abstract][Full Text] [Related]
28. Antithrombotic treatment in peripheral artery disease.
Olinic DM; Tataru DA; Homorodean C; Spinu M; Olinic M
Vasa; 2018 Feb; 47(2):99-108. PubMed ID: 29160765
[TBL] [Abstract][Full Text] [Related]
29. Ticagrelor in Triple Antithrombotic Therapy: Predictors of Ischemic and Bleeding Complications.
Fu A; Singh K; Abunassar J; Malhotra N; Le May M; Labinaz M; Glover C; Marquis JF; Froeschl M; Dick A; Hibbert B; Chong AY; So DY;
Clin Cardiol; 2016 Jan; 39(1):19-23. PubMed ID: 26748815
[TBL] [Abstract][Full Text] [Related]
30. Real clinical experiences of dual versus triple antithrombotic therapy after percutaneous coronary intervention.
Wustrow I; Sarafoff N; Haller B; Rössner L; Sibbing D; Schüpke S; Ibrahim T; Anetsberger A; Schunkert H; Laugwitz KL; Kastrati A; Bernlochner I
Catheter Cardiovasc Interv; 2018 Dec; 92(7):1239-1246. PubMed ID: 30019824
[TBL] [Abstract][Full Text] [Related]
31. Stroke and major bleeding risk in elderly patients aged ≥75 years with atrial fibrillation: the Loire Valley atrial fibrillation project.
Lip GY; Clementy N; Pericart L; Banerjee A; Fauchier L
Stroke; 2015 Jan; 46(1):143-50. PubMed ID: 25424474
[TBL] [Abstract][Full Text] [Related]
32. Contemporary Antithrombotic Treatment in Patients with Non-valvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: Rationale and Design of the Greek AntiPlatElet Atrial Fibrillation (GRAPE-AF) Registry.
Xanthopoulou I; Dragona VM; Davlouros P; Tsioufis C; Iliodromitis E; Alexopoulos D;
Cardiovasc Drugs Ther; 2018 Apr; 32(2):191-196. PubMed ID: 29679301
[TBL] [Abstract][Full Text] [Related]
33. Adherence to guidelines for the prescribing of double and triple combinations of antithrombotic agents.
Warlé-Van Herwaarden MF; Roukens M; Pop GA; Lamfers EJ; De Smet PA; Kramers C
Eur J Prev Cardiol; 2014 Feb; 21(2):231-43. PubMed ID: 22684153
[TBL] [Abstract][Full Text] [Related]
34. [Comparison of Various Regimens of Antithrombotic Therapy in Patients With Valvular Heart Disease and Coronary Artery Disease After Surgical and Interventional Interventions].
Ruzina EV; Berdibekov BS; Bulaeva NI; Kubova MC; Golukhova EZ
Kardiologiia; 2023 Jul; 63(7):47-53. PubMed ID: 37522827
[TBL] [Abstract][Full Text] [Related]
35. Association of Antithrombotic Drug Use With Incident Intracerebral Hemorrhage Location.
Boe NJ; Hald SM; Kristensen AR; Möller S; Bojsen JA; Elhakim MT; Rodrigues MA; Al-Shahi Salman R; Hallas J; García Rodríguez LA; Selim M; Goldstein LB; Gaist D
Neurology; 2024 Jun; 102(12):e209442. PubMed ID: 38771998
[TBL] [Abstract][Full Text] [Related]
36. Triple antithrombotic therapy versus dual antiplatelet therapy in patients with atrial fibrillation undergoing drug-eluting stent implantation.
Kang DO; Yu CW; Kim HD; Cho JY; Joo HJ; Choi RK; Park JS; Lee HJ; Kim JS; Park JH; Hong SJ; Lim DS
Coron Artery Dis; 2015 Aug; 26(5):372-80. PubMed ID: 25768244
[TBL] [Abstract][Full Text] [Related]
37. Risk and benefit of dual antiplatelet treatment among non-revascularized myocardial infarction patients in different age groups.
Juul N; Gislason G; Olesen JB; Lamberts M; Hansen ML; Karasoy D; Christiansen CB; Torp-Pedersen C; Sorensen R
Eur Heart J Acute Cardiovasc Care; 2017 Sep; 6(6):511-521. PubMed ID: 24936092
[TBL] [Abstract][Full Text] [Related]
38. Triple antithrombotic therapy following an acute coronary syndrome: prevalence, outcomes and prognostic utility of the HAS-BLED score.
Smith JG; Wieloch M; Koul S; Braun OÖ; Lumsden J; Rydell E; Ohman J; Scherstén F; Svensson PJ; van der Pals J
EuroIntervention; 2012 Oct; 8(6):672-8. PubMed ID: 23086784
[TBL] [Abstract][Full Text] [Related]
39. Major bleeding complications related to combined antithrombotic therapy in atrial fibrillation patients 12 months after coronary artery stenting.
Kawai H; Watanabe E; Yamamoto M; Harigaya H; Sano K; Takatsu H; Muramatsu T; Naruse H; Sobue Y; Motoyama S; Sarai M; Takahashi H; Arakawa T; Kan S; Sugiura A; Murohara T; Ozaki Y
J Cardiol; 2015 Mar; 65(3):197-202. PubMed ID: 25266323
[TBL] [Abstract][Full Text] [Related]
40. Safety and effectiveness of antithrombotic strategies in older adult patients with atrial fibrillation and non-ST elevation myocardial infarction.
Fosbol EL; Wang TY; Li S; Piccini JP; Lopes RD; Shah B; Mills RM; Klaskala W; Alexander KP; Thomas L; Roe MT; Peterson ED
Am Heart J; 2012 Apr; 163(4):720-8. PubMed ID: 22520540
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]